Back    Zoom +    Zoom -
<IPO>TRANSTHERA-B (02617.HK) IPO Today; Entry Fee $6,641.31
Recommend
8
Positive
13
Negative
8
Biopharmaceutical company TRANSTHERA-B (02617.HK) announced the details of its IPO, planning to globally offer 15.281 million shares, with 10% for the Hong Kong public offering and 90% for the international offering.

The offer price per share was HKD13.15. Entry fee for each board lot (500 shares) was HKD6,641.31. The IPO starts today (13th) and will close at noon next Wednesday (18th), with the expected listing date on June 23. The joint sponsors are CITIC Securities and Huatai International.

Related NewsCLSA: Biotech Stocks Largely Complete 1st Phase of Valuation Recovery; Liquidity & Fundamentals Expected to Improve
The company introduced five cornerstone investors for the listing, including AKESO (09926.HK), collectively subscribing to HKD130 million worth of company shares.

The company expected to raise net proceeds of approximately HKD161 million from the listing.
AASTOCKS Financial News
Website: www.aastocks.com